Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04579848 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Methotrexate in Erosive Inflammatory Hand Osteoarthritis

Study acronym: MERINO
StatusActive, Not Recruiting
PhasePhase 4
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Trial status: Recruiting to Active, Not Recruiting
    • Site details revised
    v11
  2. Primary completion date: Jun 30, 2026 to Dec 2026
    • Study completion date: Dec 31, 2026 to Dec 2026
    v10
  3. Primary completion date: Dec 31, 2025 to Jun 30, 2026
    • Study completion date: Jun 30, 2026 to Dec 31, 2026
    v9
  4. Re-verified, no change to tracked fieldsv8
  5. Primary completion date: Jun 30, 2025 to Dec 31, 2025
    • Enrollment target: 153 to 163
    • Study completion date: Dec 31, 2025 to Jun 30, 2026
    • Secondary endpoints: 26 to 25
    v7
Show 5 earlier versionsHide 5 earlier versions
  1. Primary completion date: Apr 30, 2024 to Jun 30, 2025
    • Enrollment target: 170 to 153
    • Study completion date: Oct 30, 2024 to Dec 31, 2025
    v6
  2. Primary completion date: Apr 30, 2023 to Apr 30, 2024
    • Study completion date: Oct 30, 2023 to Oct 30, 2024
    v5
  3. Enrollment target: 210 to 170v4
  4. Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Mar 15, 2021 to Aug 12, 2021
    • Site details revised
    v3
  5. Start date: Nov 30, 2020 to Mar 15, 2021v2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
A placebo-controlled randomized controlled trial exploring the effect of methotrexate on pain, function and structural outcomes in erosive inflammatory hand osteoarthritis.
Trial Details
NCT Number NCT04579848
Lead Sponsor Diakonhjemmet Hospital
Collaborators: Oslo University Hospital
Conditions
(from sponsor)		 Hand Osteoarthritis, Erosive Osteoarthritis
Enrollment 163 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov